Review: taking Tizanidine hydrochloride and Metoprolol tartrate together


Summary

Drug interactions are reported among people who take Tizanidine hydrochloride and Metoprolol tartrate together. This review analyzes the effectiveness and drug interactions between Tizanidine hydrochloride and Metoprolol tartrate. It is created by eHealthMe based on reports of 445 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Tizanidine hydrochloride and Metoprolol tartrate >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Tizanidine Hydrochloride

Tizanidine hydrochloride has active ingredients of tizanidine hydrochloride. It is often used in muscle spasms. (latest outcomes from Tizanidine hydrochloride 1,622 users)

Metoprolol Tartrate

Metoprolol tartrate has active ingredients of metoprolol tartrate. It is often used in high blood pressure. (latest outcomes from Metoprolol tartrate 41,185 users)

On Aug, 29, 2016

445 people who take Tizanidine Hydrochloride, Metoprolol Tartrate are studied.


Number of reports submitted per year:

Tizanidine hydrochloride and Metoprolol tartrate drug interactions.

Drug effectiveness over time:

Tizanidine Hydrochloride:
  • < 1 month: 0.0% - (0 of 1 people)
  • 1 - 6 months: 20.0% - (1 of 5 people)
  • 6 - 12 months: 25.0% - (1 of 4 people)
  • 1 - 2 years: 50.0% - (2 of 4 people)
  • 2 - 5 years: 0.0% - (0 of 3 people)
  • 5 - 10 years: 100.0% - (1 of 1 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)
Metoprolol Tartrate:
  • < 1 month: 50.0% - (1 of 2 people)
  • 1 - 6 months: 0.0% - (0 of 1 people)
  • 6 - 12 months: 0.0% - (0 of 0 people)
  • 1 - 2 years: 50.0% - (1 of 2 people)
  • 2 - 5 years: 37.0% - (3 of 8 people)
  • 5 - 10 years: 80.0% - (4 of 5 people)
  • 10+ years: 100.0% - (1 of 1 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Tizanidine Hydrochloride:
  • female: 35.0% - (6 of 17 people)
  • male: 0.0% - (0 of 2 people)
Metoprolol Tartrate:
  • female: 62.0% - (10 of 16 people)
  • male: 0.0% - (0 of 3 people)

Drug effectiveness by age:

Tizanidine Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 33.0% - (1 of 3 people)
  • 40-49: 27.0% - (3 of 11 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 100.0% - (1 of 1 people)
Metoprolol Tartrate:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 0 people)
  • 20-29: 100.0% - (1 of 1 people)
  • 30-39: 66.0% - (2 of 3 people)
  • 40-49: 60.0% - (6 of 10 people)
  • 50-59: 0.0% - (0 of 3 people)
  • 60+: 50.0% - (1 of 2 people)

Most common drug interactions over time *:

< 1 month:
  • abdominal pain upper
  • alanine aminotransferase increased
  • arthralgia
  • aspartate aminotransferase increased
  • blood alkaline phosphatase increased
  • blood lactate dehydrogenase increased
  • blood pressure increased
  • cerebral infarction
  • crying
  • decreased appetite
1 - 6 months:
  • abdominal distension
  • abdominal neoplasm
  • abdominal pain aggravated
  • anemia - b12 deficiency
  • anemia - hemolytic
  • bile duct pressure increased
  • bone and joint pain
  • coronary artery disease
  • fatigue
  • fecal incontinence
6 - 12 months:
  • hallucinations, mixed
  • hyaluronic acid abnormal
  • petechiae
1 - 2 years:
  • constipation
  • hallucinations, mixed
  • headache - mixed tension migraine
  • hyaluronic acid abnormal
  • nausea
  • sleep disorder
  • swallowing painful
  • swelling face
  • swelling in the abdomen
  • swelling of a joint
2 - 5 years:
  • anaemia
  • convulsion
  • fungal sepsis
  • hypokalaemia
  • hypomagnesaemia
  • neutropenia
  • neutropenic sepsis
  • pericardial effusion
  • clostridium difficile colitis
  • loss of hair
5 - 10 years:
  • abdominal distension
  • hair loss
  • abdominal neoplasm
  • abdominal pain aggravated
  • anemia - b12 deficiency
  • anemia - hemolytic
  • bile duct pressure increased
  • bone and joint pain
  • fatigue
  • fecal incontinence
10+ years:
  • hallucinations, mixed
not specified:
  • fatigue
  • dyspnoea
  • fall
  • nausea
  • pain
  • headache
  • chest pain
  • asthenia
  • depression
  • back pain

Most common drug interactions by gender *:

female:
  • fatigue
  • fall
  • nausea
  • headache
  • asthenia
  • hypertension
  • pain
  • chest pain
  • back pain
  • depression
male:
  • dyspnoea
  • hypotension
  • pain
  • chest pain
  • oedema peripheral
  • pyrexia
  • nausea
  • depression
  • diarrhoea
  • anxiety

Most common drug interactions by age *:

2-9:
  • clostridium difficile colitis
  • irritability
  • withdrawal syndrome
  • application site urticaria
  • rash
20-29:
  • confusional state
  • metabolic acidosis
  • amnesia
  • anxiety
  • aphasia
  • autonomic nervous system imbalance
  • blood chloride increased
  • disorientation
  • mental status changes
  • renal tubular acidosis
30-39:
  • paraesthesia
  • type 2 diabetes mellitus
  • arthralgia
  • cholelithiasis
  • diabetes mellitus
  • dizziness
  • drug ineffective
  • pain
  • pain in extremity
  • weight increased
40-49:
  • nausea
  • anxiety
  • headache
  • insomnia
  • fall
  • fatigue
  • balance disorder
  • pain
  • vomiting
  • chest pain
50-59:
  • fall
  • pyrexia
  • fatigue
  • chest pain
  • headache
  • pneumonia
  • dyspnoea
  • cough
  • asthenia
  • nausea
60+:
  • dyspnoea
  • renal failure
  • fatigue
  • dizziness
  • hypotension
  • asthenia
  • depression
  • pain
  • fall
  • urinary tract infection

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Tizanidine hydrochloride and Metoprolol tartrate?

Can you answer these questions?

More questions for: Tizanidine hydrochloride, Metoprolol tartrate

You may be interested in these reviews

More reviews for: Tizanidine hydrochloride, Metoprolol tartrate

On eHealthMe, Tizanidine hydrochloride (tizanidine hydrochloride) is often used to treat muscle spasms. Metoprolol tartrate (metoprolol tartrate) is often used to treat high blood pressure. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.